Principal Research Coordinator at ZIM Labs, Dr. Nidhi Sapkal will be sharing ZIM’s experience on challenges faced during technology development of thin films at CPhI Worldwide at Messe Frankfurt, Germany from October 24th to 26th. ZIM has proprietary technology for developing thin film based products named as Thinoral®. ZIM has already developed over 30 products based on Thinoral® technology. Dr. Nidhi Sapkal will be addressing the gathering of learned pharmacists and companies on the topic ‘Oral Thin Films: Innovative Dosage Form for Improving Patient Compliance’. The Thinoral technology is used to manufacture fast dissolving thin films that are instantly wettable, non-sticky, non-tacky and non-curving. They’re easy to consume and hence contribute to patient convenience and adherence. ZIM has received IPA-ACG-Scitech Award for Best Innovation in solid dosage form, December ‘16 for Thinoral®.
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt.
About ZIM Labs
ZIM Laboratories Limited is an innovative drug delivery solutions providing company targeting patient convenience and adherence. It uses proprietary technologies (modified release and taste masking), to develop and manufacture differentiated pharmaceutical products.
It is located in Nagpur, Central India and is EU-GMP, WHO-GMP Certified and ISO 9001:2008 accredited company supported by an excellent team of professionals and state-of- the-art facility.
ZIM is engaged in the activities of research and development, manufacturing, distribution and marketing of oral solid dosage formulations and pre-formulations (PFI) covering tablets, capsules, dry syrups, pellets, granules and orally disintegrating strips (ODS). More information available on ZIM